Skip to main content

Aman Opneja

Assistant Professor of Medicine
Medicine, Medical Oncology

Scholarly Works


Abstract CT184: Preliminary results of first-line botensilimab (BOT) and balstilimab (BAL) optimization in microsatellite stable colorectal cancer (MSS CRC) without liver, bone, or brain metastasis (BBOpCo)

Conference Cancer Research · April 17, 2026 AbstractPatients (pts) with metastatic (met) MSS CRC are treated with sequential lines of chemotherapy (chemo), but most experience progression and prolonged toxicities during their disease course. BOT is ... Full text Cite

Abstract CT073: FiREBOLT: A phase 1 study evaluating radioligand therapy with LY4337713 in adults with select FAP+ solid tumors (Trial in progress)

Conference Cancer Research · April 17, 2026 AbstractBackground:Fibroblast activation protein (FAP) is a transmembrane glycoprotein highly expressed on cancer-associated fi ... Full text Cite

Immune checkpoint blockade in locally advanced rectal cancer with deficient DNA mismatch repair: retrospective multicenter experience.

Journal article ESMO Open · January 2026 BACKGROUND: Prospective, single-institution studies in deficient DNA mismatch repair (dMMR) locally advanced rectal cancer (LARC) have shown high rates of complete clinical response (cCR) to neoadjuvant immune checkpoint inhibitor (ICI) monotherapy. PATIEN ... Full text Link to item Cite

Immune checkpoint blockade in locally advanced rectal cancer with deficient mismatch repair (dMMR): Retrospective multicenter experience.

Conference Journal of Clinical Oncology · June 2025 e15628Background: Total neoadjuvant therapy (TNT) with cytotoxic chemotherapy and chemoradiation followed by surgical resecti ... Full text Cite

Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014.

Journal article Cancer Med · July 2021 BACKGROUND: This study analyzes the pattern of use of single agent anticancer therapy (SAACT) in the treatment and survival of advanced hepatocellular carcinoma (aHCC) before and after sorafenib was FDA approved in 2007. METHODS: Adult patients diagnosed w ... Full text Link to item Cite

Monitoring DOACs with a Novel Dielectric Microsensor: A Clinical Study.

Journal article Thromb Haemost · January 2021 BACKGROUND:  There are acute settings where assessing the anticoagulant effect of direct oral anticoagulants (DOACs) can be useful. Due to variability among routine coagulation tests, there is an unmet need for an assay that detects DOAC effects within min ... Full text Link to item Cite

Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing.

Journal article Thromb Res · July 2019 Wound healing is a complex process that consists of multiple phases, each of which are indispensable for adequate repair. Timely initiation and resolution of each of these phases namely, hemostasis, inflammation, proliferation and tissue remodeling, is cri ... Full text Link to item Cite

The role of neutrophils in thrombosis.

Journal article Thromb Res · October 2018 Despite significant evidence implicating an important role for neutrophils in thrombosis, their impact on the thrombotic process has remained a matter of controversy. Until 2010, platelets, coagulation factors, fibrinogen and monocytes were implicated in t ... Full text Link to item Cite

Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center.

Journal article Am J Clin Oncol · December 2017 PURPOSE: The majority of the cancer survivors in the United States are 5 or more years beyond their diagnosis. The follow-up care of these individuals remains a major concern for survivors and for the cancer care system. The purpose of this study was to ch ... Full text Link to item Cite

Unusual Paraneoplastic Presentation of Cholangiocarcinoma

Journal article Case Reports in Medicine · January 1, 2015 Introduction. Cutaneous paraneoplastic syndromes are a heterogeneous group of skin manifestations that occur in relation to many known malignancies. Paraneoplastic occurrence of SCLE has been noted but is not commonly reported. SCLE association with cholan ... Full text Cite

Adult Soft Tissue Sarcoma

Book section · January 1, 2015 Cite